EPCAM and malignant colon neoplasm: These studies have shown that CD133+ colon cancer cells represent about 2.5% of the bulk tumor cells, are devoid of intestinal differentiation markers such as cytokeratin 20 (CK20), while expressing the epithelial adhesion molecule EpCAM.